Preferred Label : Bevacizumab/Paclitaxel/Topotecan Regimen;
NCIt synonyms : Hycamtin/Taxol/Avastin Regimen; Hycamtin-Taxol-Avastin Regimen; Topotecan-Paclitaxel-Bevacizumab; Topotecan/Paclitaxel/Bevacizumab; Topotecan-Paclitaxel-Bevacizumab Regimen; PACLTOPO BEVA Regimen; TPB Regimen; Topotecan/Paclitaxel/Bevacizumab Regimen;
NCIt related terms : Paclitaxel, Topotecan, Bevacizumab; Paclitaxel, Topotecan, Bevacizumab-equi; Paclitaxel, Topotecan, Bevacizumab-aybi; Paclitaxel, Topotecan, Bevacizumab-awwb; Paclitaxel, Topotecan, Bevacizumab-adcd; Paclitaxel, Topotecan, Bevacizumab-bvzr; Paclitaxel, Topotecan, Bevacizumab-maly; Paclitaxel, Topotecan, Bevacizumab-onbe;
NCIt definition : A regimen consisting of topotecan, paclitaxel and bevacizumab that is used for the
treatment of cervical and vaginal cancer.;
NCI Metathesaurus CUI : CL523553;
Codes from synonyms : 11554; 127465; 127169; 127243; 127539; 127613; 127317; 127391;
Origin ID : C136242;
UMLS CUI : C4526516;
Est indiqué pour
- Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
- regimen_has_accepted_use_for_disease
